Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an electrolyte essential for cellular function, nerve impulse transmission, and muscle contraction. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium supplementation in patients receiving diuretics or corticosteroids. * Treatment of digitalis toxicity. ## Adult Dosing * **Oral:** * **Hypokalemia Treatment:** 20-100 mEq per day in 2-4 divided doses. Severe deficiency may require up to 200 mEq/day. * **Prevention:** 20-40 mEq per day. * **Maximum single oral dose:** Generally considered 20 mEq to minimize gastrointestinal upset. * **Intravenous (IV):** * **Hypokalemia Treatment:** Typically administered at a rate of 10-20 mEq/hour. * **Maximum infusion rate:** Generally **10 mEq/hour** peripherally and **20 mEq/hour** centrally for rates exceeding 10 mEq/hour. Higher rates (up to 40 mEq/hour) may be used in severe, life-threatening hypokalemia in a monitored setting. * **Maximum concentration:** **40 mEq/L** peripherally; **80 mEq/L** centrally. Higher concentrations may be used in emergencies with cardiac monitoring. * **Total daily dose:** Rarely exceeds 200 mEq/day. Dosing depends on serum potassium levels and clinical assessment. Specific protocols may guide IV potassium administration, particularly for rapid correction. ## Pediatric Dosing * **Oral:** * **Treatment:** 2-5 mEq/kg/day in divided doses, not to exceed adult doses. * **Prevention:** 1-2 mEq/kg/day. * **Intravenous (IV):** * **Treatment:** 0.5-1 mEq/kg per dose, infused at a rate **not exceeding 0.3-0.5 mEq/kg/hour** (max 10-20 mEq/hour). * **Maximum daily dose:** Generally **100 mEq/day** or as per protocol. Dosing must be individualized based on serum potassium, age, weight, and clinical status. Pediatric critical care protocols often dictate IV potassium administration. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Dosage reduction is often necessary. Monitor potassium levels closely. May require avoidance in severe renal failure. ## Contraindications * Hyperkalemia. * Conditions that predispose to hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, severe tissue trauma, burns). * Intestinal obstruction or delayed gastric emptying (oral formulations). ## Adverse Effects * **Gastrointestinal (Oral):** Nausea, vomiting, diarrhea, abdominal pain, gastrointestinal bleeding, ulceration, perforation. * **Cardiovascular (IV):** Arrhythmias, cardiac arrest (especially with rapid infusion or hyperkalemia). * **Other:** Hyperkalemia (signs include muscle weakness, paresthesia, fatigue, confusion, bradycardia, hypotension, arrhythmias). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene), ACE inhibitors, ARBs, NSAIDs, cyclosporine, tacrolimus:** Increase the risk of hyperkalemia. * **Digoxin:** Hypokalemia increases the risk of digoxin toxicity. Hyperkalemia decreases the efficacy of digoxin. * **Neuromuscular blocking agents:** May potentiate neuromuscular blockade. ## Monitoring * **Serum electrolytes (especially potassium and magnesium):** Frequently, especially during IV therapy, with dose changes, or in patients with renal impairment. * **Electrocardiogram (ECG):** Essential for monitoring for signs of hyperkalemia, particularly with IV administration or known/suspected hyperkalemia. * **Renal function (BUN, creatinine):** To assess the need for dose adjustment. * **Urine output:** To assess renal perfusion. ## Clinical Pearls * Oral potassium chloride can be irritating to the gastrointestinal tract; always dilute with sufficient fluid (e.g., 8 oz water or juice) and instruct patients to take with food or after meals. * Liquid formulations are generally preferred in pediatrics and for patients with swallowing difficulties. * Rapid IV infusion of potassium chloride is dangerous and can lead to fatal cardiac arrhythmias; administer slowly and with close cardiac monitoring. * Always verify serum potassium levels before administering potassium replacement, especially IV. * Correct hypomagnesemia concurrently if present, as it can impair potassium repletion. --- *This information is intended for healthcare professionals. Always consult the most current prescribing information, institutional protocols, and patient-specific factors before making therapeutic decisions.*